参考文献/References:
[1]Kelly BB,Narula J,Fuster V.Recognizing global burden of cardiovascular disease and related chronic diseases[J].Mt Sinai J Med,2012,79(6):632-640. [2]陈伟伟,高润霖,刘力生,等.《中国心血管病报告_2017》概要[J].中国循环杂志,2018,33(1):1-8. [3]Alenghat FJ,Davis AM.Management of Blood Cholesterol[J].JAMA,2019,321(8):800-801. [4]Steen DL,Khan I,Ansell D,et al.Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence(NICE)2014 lipid modification guidelines[J].BMJ Open,2017,7(2):e13255. [5]Catapano AL,Graham I,De Backer G,et al.2016 ESC/EAS Guidelines for the Management of Dyslipidaemias[J].Eur Heart J,2016,37(39):2999-3058. [6]Grundy SM,Stone NJ,Bailey AL,et al.2018AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].Circulation,2019,139(25):e1082-e1143. [7]Maiolino G,Bisogni V,Rossitto G,et al.Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications[J].World Journal of Cardiology(WJC),2015(10):609-620. [8]Kheirandish-Gozal L,Philby MF,Qiao Z,et al.Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Elevated Lipoprotein‐Associated Phospholipase A2 Plasma Activity Levels[J].Journal of the American Heart Association,2017,6(2):e004923. [9]Abajobir AA,Abate KH,Abbafati C,et al.Global,Regional,and national comparative risk assessment of 84 behavioural,environmental and occupational,and metabolic risks or clusters of risks,1990-2016:asystematic analysis for the global burden of disease study 2016[J].Lancet,2017,390(10100):1345-1422. [10]Beaglehole R,Bonita R.Global public health:a scorecard[J].Lancet,2008,372(9654):1988-1996. [11]杜文婷,刘萍.颈动脉超声检测在心脑血管疾病中的应用概况[J].中西医结合心脑血管病杂志,2016,14(10):1117-1120. [12]Koskinen JS,Kyto V,Juonala M,et al.Childhood risk factors and carotid atherosclerotic plaque in adulthood: The Cardiovascular Risk in Young Finns Study[J].Atherosclerosis,2020(293):18-25. [13]Thompson A,Gao P,Orfei L,et al.Lipoprotein-associated phospholipase A(2)and risk of coronary disease, stroke, and mortality:collaborative analysis of 32 prospective studies[J].Lancet,2010,375(9725):1536-1544. [14]Pencina KM,Thanassoulis G,Wilkins JT,et al.Trajectories of Non-HDL Cholesterol Across Midlife:Implications for Cardiovascular?Prevention[J].J Am Coll Cardiol,2019,74(1):70-79.